BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25681111)

  • 1. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
    Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.
    Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW
    Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
    Cauchard J; Sevin C; Ballet JJ; Taouji S
    Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
    Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
    Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals.
    Sanz MG; Oliveira AF; Page A; Horohov DW
    Vet Rec; 2014 Nov; 175(19):485. PubMed ID: 25117301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals.
    Phumoonna T; Barton MD; Heuzenroeder MW
    J Vet Med B Infect Dis Vet Public Health; 2005 Aug; 52(6):291-5. PubMed ID: 16219093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
    Haghighi HR; Prescott JF
    Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.
    Lohmann KL; Lopez AM; Manning ST; Marques FJ; Brownlie R; Allen AL; Sangster AE; Mutwiri G; Gerdts V; Potter A; Townsend HG
    Can J Vet Res; 2013 Jul; 77(3):161-9. PubMed ID: 24101791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
    Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
    Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
    Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
    Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals.
    Phumoonna T; Muscatello G; Chicken C; Gilkerson JR; Browning GF; Barton MD; Heuzenroeder MW
    J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):126-32. PubMed ID: 16629724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
    Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G
    Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
    Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
    Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.
    Lopez AM; Hines MT; Palmer GH; Alperin DC; Hines SA
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1270-6. PubMed ID: 12414760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
    Vanniasinkam T; Barton MD; Heuzenroeder MW
    Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
    Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Vinacur M; Cortez-Ramirez SC; Sutter PJ; Meyer SC; Bordin AI; Vlock DR; Pier GB; Cohen ND
    PLoS One; 2021; 16(8):e0250133. PubMed ID: 34437551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi.
    Taouji S; Nomura I; Giguère S; Tomomitsu S; Kakuda T; Ganne V; Takaï S
    Vaccine; 2004 Mar; 22(9-10):1114-23. PubMed ID: 15003638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a live, attenuated, potential vaccine strain of R. equi expressing vapA and the virR operon, and virulence assessment in the mouse.
    Whitehead AE; Parreira VR; Hewson J; Watson JL; Prescott JF
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):479-84. PubMed ID: 22088674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
    Phumoonna T; Barton MD; Vanniasinkam T; Heuzenroeder MW
    Vaccine; 2008 May; 26(20):2457-65. PubMed ID: 18423949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals.
    Legere RM; Poveda C; Ott JA; Bray JM; Villafone EG; Silveira BPD; Kahn SK; Martin CL; Mancino C; Taraballi F; Criscitiello MF; Berghman L; Bordin AI; Pollet J; Cohen ND
    Am J Vet Res; 2024 Feb; 85(2):. PubMed ID: 38056076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.